These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6668097)

  • 61. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?
    Akcicek F; Yalniz T; Basci A; Ok E; Mees EJ
    BMJ; 1995 Jan; 310(6973):162-3. PubMed ID: 7833755
    [No Abstract]   [Full Text] [Related]  

  • 62. Disposition kinetics of furosemide in dogs.
    El-Sayed MG; Atef M; El-Gendi AY; Youssef SA
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):4-10. PubMed ID: 7325754
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Impaired plasma protein binding of furosemide in nephrotic syndrome and uremia].
    Takahashi F
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):665-80. PubMed ID: 7176178
    [No Abstract]   [Full Text] [Related]  

  • 64. In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
    Voelker JR; Jameson DM; Brater DC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):772-8. PubMed ID: 2778714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
    Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
    Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plasma and urinary kinetics of furosemide in newborn infants.
    Tuck S; Morselli P; Broquaire M; Vert P
    J Pediatr; 1983 Sep; 103(3):481-5. PubMed ID: 6886918
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interactions of dihydralazine with furosemide in hypertonic patients.
    Siegmund W; Kairies M; Franke G; Donner I; Biebler KE
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Furosemide disposition in cirrhosis.
    Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.
    Kapur G; Valentini RP; Imam AA; Mattoo TK
    Clin J Am Soc Nephrol; 2009 May; 4(5):907-13. PubMed ID: 19406963
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Furosemide].
    Kerremans AL
    Ned Tijdschr Geneeskd; 1986 Sep; 130(36):1588-90. PubMed ID: 3762762
    [No Abstract]   [Full Text] [Related]  

  • 71. Disposition and absolute bioavailability of furosemide in healthy males.
    Waller ES; Hamilton SF; Massarella JW; Sharanevych MA; Smith RV; Yakatan GJ; Doluisio JT
    J Pharm Sci; 1982 Oct; 71(10):1105-8. PubMed ID: 7143205
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The individual variation in pharmacokinetics and pharmacodynamics of furosemide in young normal male subjects.
    Andreasen F; Christensen CK; Jacobsen FK; Jansen J; Mogensen CE; Pedersen OL
    Eur J Clin Invest; 1982 Jun; 12(3):247-55. PubMed ID: 6809473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
    Agarwal R; Gorski JC; Sundblad K; Brater DC
    J Am Soc Nephrol; 2000 Jun; 11(6):1100-1105. PubMed ID: 10820174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Furosemide binding to human albumin and plasma of nephrotic children.
    Prandota J; Pruitt AW
    Clin Pharmacol Ther; 1975 Feb; 17(2):159-65. PubMed ID: 235396
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Pharmacokinetics and electrolyte balance following administration of furosemide in pregnant women with E gestosis].
    Peiker G; Traeger A; Stiller K; Müller B
    Pharmazie; 1984 May; 39(5):336-9. PubMed ID: 6473496
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Some changes in the content of electrolytes in the urine, blood plasma and erythrocytes in children with nephrotic syndrome during hormone therapy].
    Zabirov VKh
    Pediatriia; 1966 Jul; 45(7):8-12. PubMed ID: 5988425
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacokinetics and pharmacodynamics of furosemide in geriatric patients.
    Mühlberg W; Platt D; Neubig E
    Arch Gerontol Geriatr; 1986 Oct; 5(3):249-63. PubMed ID: 3800492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Bumetanide (Burinex Leo)--a new potent diuretic. Comparative study of high-dose intravenous therapy with bumetanide and furosemide in drug-intoxicated patients].
    Berg KJ; Gisholt K; Wideroe T
    Tidsskr Nor Laegeforen; 1973 Apr; 93(12):843-6. PubMed ID: 4752584
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effect of a new oral diuretic, ethacrynic acid, in normal individuals and patients with cardiac or nephrotic syndrome on diuresis and renal function].
    Koçak N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1968; 34(8):482-501. PubMed ID: 5732893
    [No Abstract]   [Full Text] [Related]  

  • 80. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K
    Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.